Literature DB >> 11700888

A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.

K T Mai1, D C Landry, S J Robertson, A S Commons, B F Burns, A Thijssen, J Collins.   

Abstract

Clear cell (CRCC), papillary (PRCC) and chromophobe (CHRC) renal cell carcinoma (RCC) are the three most frequent subtypes of RCC. The rate and distribution of their metastatic lesions have not been well documented. We compared metastatic RCC according to subtype and primary tumor characteristics to better understand their behavior and to aid in the diagnosis of metastatic RCC. Pathology reports and clinical charts related to 283 CRCC, 48 PRCC and 13 CHRCC, including their respective sarcomatoid variants, were reviewed. A hundred and thirty-seven CRCC, 5 PRCC and 1 CHRCC with metastases were identified. CRCC and non-CRCC (PRCC and CHRCC) had different patterns of metastasis and primary tumor growth. CRCC metastases were predominantly distributed in lungs, bone, brain, lymph nodes, and adrenal glands. The associated primary CRCC measured 1.5 to 15 cm, were of all grades and stages, and were often associated with invasion of small or large veins. Three PRCC had regional lymph node metastases, 1 PRCC had both regional and mediastinal lymph node metastases. Bone metastasis was present in 1 case each of PRCC and CHRCC. One PRCC with metastasis solely to regional nodes measured 4 cm. The other 4 cases of PRCC with regional lymph node and/or distant metastases as well as the CHRCC with distant metastases were greater than 8 cm in diameter. In metastasizing and non-metastasizing non-CRCC, invasion of small veins was rare and invasion of renal veins was not seen. We cannot comment with any certainty on the metastatic behavior of CHRCC. In our experience, PRCC tend to loco-regional invasion with lymph node spread. They have a low potential for vascular invasion and distant metastases that likely occur only at late stages of the disease. CRCC has a propensity for vascular invasion and may be associated with distant metastasis at an early stage. Therefore, metastatic RCC at a distant location are most likely to be of CRCC origin than PRCC origin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700888     DOI: 10.1078/0344-0338-00144

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  19 in total

1.  Tc-99m Tetrofosmin SPECT for the differentiation of a cerebellar hemorrhage mimicking a brain metastasis from a renal cell carcinoma.

Authors:  G A Alexiou; J A Bokharhii; A P Kyritsis; K S Polyzoidis; A D Fotopoulos
Journal:  J Neurooncol       Date:  2006-03-31       Impact factor: 4.130

2.  Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.

Authors:  Arezoo Rasti; Maryam Abolhasani; Leili Saeednejad Zanjani; Mojgan Asgari; Mitra Mehrazma; Zahra Madjd
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

3.  (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.

Authors:  Emre Demirci; Meltem Ocak; Levent Kabasakal; Clemens Decristoforo; Zübeyir Talat; Metin Halaç; Bedii Kanmaz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-23       Impact factor: 9.236

4.  Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.

Authors:  Liping Shi; Long Xiao; Baoli Heng; Shijie Mo; Weijun Chen; Zexuan Su
Journal:  Int Urol Nephrol       Date:  2017-03-27       Impact factor: 2.370

5.  Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.

Authors:  Arezoo Rasti; Zahra Madjd; Maryam Abolhasani; Mitra Mehrazma; Leila Janani; Leili Saeednejad Zanjani; Mojgan Asgari
Journal:  Clin Exp Med       Date:  2017-12-04       Impact factor: 3.984

6.  Papillary renal cell carcinoma with metastatic laparoscopic port site and vaginal involvement: a case report.

Authors:  Xue En Chuang; Hwai Liang Loh; Hong Gee Sim; Kah Leng Fong; Min-Han Tan
Journal:  J Med Case Rep       Date:  2011-04-01

7.  The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.

Authors:  Thomas Steiner; Hartmut Kirchner; Michael Siebels; Christian Doehn; Hans Heynemann; Zoltan Varga; Detlef Rohde; Joerg Schubert; Dieter Jocham; Christian Stief; Paolo Fornara; Rainer Hofmann; Stefan Loening; Jan Roigas
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-12       Impact factor: 4.553

8.  Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report.

Authors:  Takeo Kosaka; Shuji Mikami; Akira Miyajima; Mototsugu Oya
Journal:  Clin Exp Nephrol       Date:  2008-01-22       Impact factor: 2.801

9.  Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.

Authors:  Rodrigo A Ledezma; Edris Negron; Gladell P Paner; Chris Rjepaj; Danny Lascano; Mohammed Haseebuddin; Pankaj Dangle; Arieh L Shalhav; Henry Crist; Jay D Raman; G Joel DeCastro; Lara Harik; Monika Paroder; Robert G Uzzo; Alexander Kutikov; Scott E Eggener
Journal:  World J Urol       Date:  2015-09-25       Impact factor: 4.226

10.  The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis.

Authors:  Dharam Kaushik; Brian J Linder; R Houston Thompson; Manuel S Eisenberg; Christine M Lohse; John C Cheville; Bradley C Leibovich; Stephen A Boorjian
Journal:  Urology       Date:  2013-05-01       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.